Carotid ultrasound may improve CVD risk assessment in patients with inflammatory skin condition

Carotid ultrasound improves the cardiovascular risk stratification of individuals with the skin condition hidradenitis suppurativa (HS), according to a study published Jan. 4 in PLOS One.

As part of the study, researchers performed carotid ultrasound on 60 HS patients without a history of cardiovascular events, diabetes or chronic kidney disease, according to Cardiovascular Business. They also assessed each patient’s risk for cardiovascular disease based on the common predictive tool, the Framingham Risk Score (FRS). The objective of the ultrasounds was to test for atherosclerotic plaques.

“Based on our data, we recommended the use of carotid (ultrasound) in HS-patients with an intermediate risk for cardiovascular disease,” lead author Marcos Antonio Gonzalez-Lopez, MD, PhD, and colleagues wrote in the study. “Low-risk HS individuals aged 50 years and older, active smokers, with severe or longstanding disease (less than 20 years) should be considered for carotid ultrasonography assessment according to an individualized clinical evaluation.”

Read more at Cardiovascular Business:

 

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.